PWR
75
4
ROP
71
6
ORCL
67
2
AAL
50
2
NI
62
4
KIM
54
-2
CHK
41
2
VLO
40
5
MCD
50
3
VIX
15
-10
RRC
70
2
HAS
46
-4
GE
65
4
CA
44
8
HOG
42
2
HP
32
-2
DFS
68
6
LH
58
2
EXR
59
4
APA
27
2
PWR
75
4
ROP
71
6
ORCL
67
2
AAL
50
2
NI
62
4
KIM
54
-2
CHK
41
2
VLO
40
5
MCD
50
3
VIX
15
-10
RRC
70
2
HAS
46
-4
GE
65
4
CA
44
8
HOG
42
2
HP
32
-2
DFS
68
6
LH
58
2
EXR
59
4
APA
27
2
Financhill
Back

TransMedics Group 10K Form

Buy
71

TMDX
TransMedics Group

Last Price:
134.88
Seasonality Move:
23.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TMDX News And Ratings

See the #1 stock for the next 7 days that we like better than TMDX

TMDX Financial Statistics

Sales & Book Value

Annual Sales: $241.62M
Cash Flow: $-47.61M
Price / Cash Flow: 0
Annual Sales: $4.85
Price / Book: 28.12

Profitability

EPS (TTM): -0.34000
Net Income (TTM): $-10.2M
Gross Margin: $154.09M
Return on Equity: -6.7%
Return on Assets: -1.65%

TransMedics Group Earnings Forecast

Key TransMedics Group Financial Ratios

  • The Gross Profit Margin over the past 8 years for TMDX is 63.77%.
  • The Selling, General & Administrative Expenses for TMDX have been equal to 49.48% of Gross Profit Margin.
  • The Research & Development expenses have been 26.18% of Revenue.
  • The Interest Expense is -43.12% of Operating Income.
  • The Net Earning history of TMDX is -10.36% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 5 years.

TransMedics Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: TMDX
CUSIP: 89377M
Website: transmedics.com

Debt

Debt-to-Equity Ratio: 3.18
Current Ratio: 9.72
Quick Ratio: 8.6

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 184.04

TMDX Technical Analysis vs Fundamental Analysis

Buy
71
TransMedics Group (TMDX) is a Buy

Is TransMedics Group a Buy or a Sell?

  • TransMedics Group stock is rated a Buy
    The current TransMedics Group [TMDX] share price is $136.14. The Score for TMDX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.